Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial.
Morielli AR, Usmani N, Boulé NG, Severin D, Tankel K, Joseph K, Nijjar T, Fairchild A, Courneya KS. Morielli AR, et al. Among authors: severin d. Clin Colorectal Cancer. 2021 Sep;20(3):216-226. doi: 10.1016/j.clcc.2021.05.004. Epub 2021 May 26. Clin Colorectal Cancer. 2021. PMID: 34158253 Clinical Trial.
Should Stereotactic Radiosurgery Be Considered for Salvage of Intracranial Recurrence after Prophylactic Cranial Irradiation or Whole Brain Radiotherapy in Small Cell Lung Cancer? A Population-Based Analysis and Literature Review.
Fairchild A, Guest N, Letcher A, Mazure B, Ghosh S, Gabos Z, Chu KP, Debenham B, Nijjar T, Severin D, Scrimger R, Roa W, Yee D. Fairchild A, et al. Among authors: severin d. J Med Imaging Radiat Sci. 2020 Mar;51(1):75-87.e2. doi: 10.1016/j.jmir.2019.10.001. Epub 2019 Nov 20. J Med Imaging Radiat Sci. 2020. PMID: 31759940 Review.
Effects of exercise during and after neoadjuvant chemoradiation on symptom burden and quality of life in rectal cancer patients: a phase II randomized controlled trial.
Morielli AR, Boulé NG, Usmani N, Tankel K, Joseph K, Severin D, Fairchild A, Nijjar T, Courneya KS. Morielli AR, et al. Among authors: severin d. J Cancer Surviv. 2023 Aug;17(4):1171-1183. doi: 10.1007/s11764-021-01149-w. Epub 2021 Nov 29. J Cancer Surviv. 2023. PMID: 34841461 Clinical Trial.
Does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?
Abraham AG, Joseph K, Spratlin JL, Zebak S, Alba V, Iafolla M, Ghosh S, Abdelaziz Z, Lui A, Paulson K, Bedard E, Chua N, Tankel K, Koski S, Scarfe A, Severin D, Zhu X, King K, Easaw JC, Mulder KE. Abraham AG, et al. Among authors: severin d. Clin Oncol (R Coll Radiol). 2022 Sep;34(9):e369-e376. doi: 10.1016/j.clon.2022.05.011. Epub 2022 Jun 7. Clin Oncol (R Coll Radiol). 2022. PMID: 35680509 Clinical Trial.
67 results